4BZR

Human testis angiotensin converting enzyme in complex with K-26

4BZR の概要

• エントリーDOI: 10.2210/pdb4bzr/pdb
• 関連するPDBエントリー: 4BZS
• 分子名称: ANGIOTENSIN-CONVERTING ENZYME, beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ACETATE ION, ... (9 entities in total)
• 機能のキーワード: hydrolase, antihypertensive agents, zinc metallopeptidase
• 由来する生物種: HOMO SAPIENS (HUMAN)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 70108.13

構造登録者

Kramer, G.J.,Mohd, A.,Schwager, S.L.U.,Masuyer, G.,Acharya, K.R.,Sturrock, E.D.,Bachmann, B.O. (登録日: 2013-07-29, 公開日: 2014-02-26, 最終更新日: 2024-10-23)

主引用文献

Kramer, G.J.,Mohd, A.,Schwager, S.L.U.,Masuyer, G.,Acharya, K.R.,Sturrock, E.D.,Bachmann, B.O.
Interkingdom Pharmacology of Angiotensin-I Converting Enzyme Inhibitor Phosphonates Produced by Actinomycetes
Acs Med.Chem.Lett., 5:346-, 2014

PubMed Abstract: The K-26 family of bacterial secondary metabolites are N-modified tripeptides terminated by an unusual phosphonate analog of tyrosine. These natural products, produced via three different actinomycetales, are potent inhibitors of human angiotensin-I converting enzyme (ACE). Herein we investigate the interkingdom pharmacology of the K-26 family by synthesizing these metabolites and assessing their potency as inhibitors of both the N-terminal and C-terminal domains of human ACE. In most cases, selectivity for the C-terminal domain of ACE is displayed. Co-crystallization of K-26 in both domains of human ACE reveals the structural basis of the potent inhibition and has shown an unusual binding motif that may guide future design of domain-selective inhibitors. Finally, the activity of K-26 is assayed against a cohort of microbially produced ACE relatives. In contrast to the synthetic ACE inhibitor captopril, which demonstrates broad interkingdom inhibition of ACE-like enzymes, K-26 selectively targets the eukaryotic family.

PubMed: 24900839
DOI: 10.1021/ML4004588

実験手法

X-RAY DIFFRACTION (1.84 Å)